 |
HERLEV, Denmark, May 8, 2025 /PRNewswire/ -- Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used with the ADAPT formula (age, diabetes status, PRO-C3, platelets), assesses liver fibrosis severity – a disease responsible for approximately one in every 25 deaths worldwide.
The nordicPRO-C3â„¢ biomarker is already validated in Nordic Bioscience CAP-CLIA certified laboratory in Denmark. This demonstrates that Nordic Bioscience is dedicated to helping patients in a precision medicine driven approach, and our Platform provides the quality needed for regulatory approval.
Nordic Bioscience's scientists have over that last 10 years published more than 250 scientific papers on PRO-C3 making us the leading place for research within PRO-C3 and fibrotic related diseases.
PRO-C3 is the first of the Nordic Bioscience-biomarkers from our fibrosis panel which has been CE-approved. 40% of deaths in the western world are associated with alterations of organs such as the liver, and we provide the tools to quantify this. These are the tools of modern clinical chemistry.
"The Elecsys PRO-C3 test is the first test launched from the collaboration between Nordic Bioscience and Roche Diagnostics. We are proud that our technology becomes globally available to make a difference for patients." said Morten Karsdal, CEO of Nordic Bioscience.
About PRO-C3
PRO-C3 was invented by Nordic Bioscience and has up until now been available as a service performed in Nordic Bioscience's laboratory in Denmark using the nordicPRO-C3â„¢ test. The Elecsys PRO-C3 test is developed under a license agreement between Nordic Bioscience and Roche Diagnostics. For more information including scientific information on PRO-C3 see https://www.nordicbioscience.com/technology/biomarkers/pro-c3-nordicpro-c3
About Nordic Bioscience
Nordic Bioscience is a Danish biomarker company headquartered in Herlev, Denmark. We are engaged in biomarker development using our unique neoepitope technology. We combine our expertise in biomarker development with preclinical and clinical research. This enables us to develop biomarkers that provide fast and objective decision-making for compound selection and development in clinical trials as well as provide value for patients in a diagnostic setting. For more information about Nordic Bioscience, visit us at https://www.nordicbioscience.com
For product related inquires please use https://www.nordicbioscience.com/contact
HERLEV, Denmark, May 8, 2025 /PRNewswire/ -- Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used with the ADAPT formula (age, diabetes status, PRO-C3, platelets), assesses liver fibrosis severity – a disease responsible for approximately one in every 25 deaths worldwide.
The nordicPRO-C3â„¢ biomarker is already validated in Nordic Bioscience CAP-CLIA certified laboratory in Denmark. This demonstrates that Nordic Bioscience is dedicated to helping patients in a precision medicine driven approach, and our Platform provides the quality needed for regulatory approval.
Nordic Bioscience's scientists have over that last 10 years published more than 250 scientific papers on PRO-C3 making us the leading place for research within PRO-C3 and fibrotic related diseases.
PRO-C3 is the first of the Nordic Bioscience-biomarkers from our fibrosis panel which has been CE-approved. 40% of deaths in the western world are associated with alterations of organs such as the liver, and we provide the tools to quantify this. These are the tools of modern clinical chemistry.
"The Elecsys PRO-C3 test is the first test launched from the collaboration between Nordic Bioscience and Roche Diagnostics. We are proud that our technology becomes globally available to make a difference for patients." said Morten Karsdal, CEO of Nordic Bioscience.
About PRO-C3
PRO-C3 was invented by Nordic Bioscience and has up until now been available as a service performed in Nordic Bioscience's laboratory in Denmark using the nordicPRO-C3â„¢ test. The Elecsys PRO-C3 test is developed under a license agreement between Nordic Bioscience and Roche Diagnostics. For more information including scientific information on PRO-C3 see https://www.nordicbioscience.com/technology/biomarkers/pro-c3-nordicpro-c3
About Nordic Bioscience
Nordic Bioscience is a Danish biomarker company headquartered in Herlev, Denmark. We are engaged in biomarker development using our unique neoepitope technology. We combine our expertise in biomarker development with preclinical and clinical research. This enables us to develop biomarkers that provide fast and objective decision-making for compound selection and development in clinical trials as well as provide value for patients in a diagnostic setting. For more information about Nordic Bioscience, visit us at https://www.nordicbioscience.com
For product related inquires please use https://www.nordicbioscience.com/contact
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Nordic Bioscience announces PRO-C3 launched by Roche Diagnostics on cobas analysers
Limited Edition Drop Features Iconic Jake Burton Quotes on Snowboards, Apparel & Accessories
BURLINGTON, Vt., Jan. 9, 2026 /PRNewswire/ -- Burton is proud to unveil 'From Burton to the World', a limited-edition collection of snowboards, apparel and accessories that feature iconic quotes by late Burton founder, Jake Burton Carpenter. Professional snowboarders sponsored by Burton will debut the collection as they compete in Aspen, Colorado and Laax, Switzerland this month, with global availability beginning February 3rd on Burton.com and at select flagship stores and retail partners worldwide.
"Jake built Burton on a simple belief: snowboarding brings people together," said Donna Carpenter, Burton Owner & Chair of the Board. "While we watch individual athletes compete, what Jake understood and what our riders embody is that snowboarding has always been about community. 'From Burton to the World' celebrates this spirit. Each board carries Jake's words, but more importantly, 'From Burton to the World' represents the passion snowboarders share on and off the mountain. This collection is a tribute to Jake's vision, which is now carried forward by riders around the world who continue to push the sport while staying true to its soul."
Jake's Words, Riders' Choice
Burton Team riders worked directly with designers to select the Jake Burton quotes that resonated most with them. The result: six bold, graphic snowboards in a vibrant color palette, each featuring history-making quotes in block print.
The Collection
'HAVE AS MUCH FUN AS POSSIBLE'
Ridden by: Oliver Martin (USA), Gaon Choi (Korea), Hiroto Ogiwara (Japan), Yiming Su (China), Mitsuki Ono (Japan), Nicola Liviero (Italy), Shaotong Wu (China) and Clemens Millauer (Austria).
'RIDING IS WHERE THE ENERGY COMES FROM & IT'S ALSO WHERE IT GOES'
Ridden by: Anna Gasser (Austria), Ayumu Hirano (Japan), Hanna Karrer (Austria), Reira Iwabuchi (Japan), Romain Allemand (France), Taiga Hasegawa (Japan) and Jakub Hrones (Czech Republic).
'HERE AT BURTON WE TAKE OUR FUN SERIOUSLY'
Ridden by: Brock Crouch (USA), Jiayu Liu (China), Jonas Hasler (Switzerland), Leon Vockensperger (Germany), Øyvind Kirkhus (Norway), Telma Sarkipajou (Finland), Dane Menzies (New Zealand), Zoi Sadowski-Synnott (New Zealand).
'THE BEST THING ABOUT SNOWBOARDING – IT'S NOT HOW YOU LOOK BUT HOW YOU FEEL'
Ridden by: Shuichiro Shigeno (Japan).
'BELIEVE IN SNOWBOARDING'
Ridden by: Kaishu Hirano (Japan).
'QUESTION: IS SNOWBOARDING A FAD? ANSWER: GET SERIOUS'
Ridden by: Cam Melville Ives (New Zealand), Clemens Millauer (Austria), Lu Yang (China), Mark McMorris (Canada) and Mari Fukada (Japan).
Supporting the Riders, Celebrating the Community
Burton is proud to support this incredible global community of riders who carry forward Jake's vision every time they drop in. Fans can celebrate alongside Burton riders and own a piece of snowboarding history with the 'From Burton to the World' collection of snowboards, apparel, and accessories—available in limited quantities worldwide beginning February 3rd on Burton.com and at select Burton flagship stores and retail partners.
Photo - https://mma.prnasia.com/media2/2857988/Burton_Riders_Debut.jpg?p=medium600
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Burton Riders Debut 'From Burton to the World' Collection in Aspen & Laax
